Skip to main content
Home
FULL MENU Close Menu
Home
Home

Nancy A. Melville

News

Radioactive iodine shows no benefit in low-risk thyroid cancer

Author:
Nancy A. Melville
Publish date: March 10, 2022

The study’s take-home message for clinicians should be to “stop systematic radioiodine ablation administration in low-risk thyroid cancer patients...

  • Read More

News

Gut microbiome species predict type 2 diabetes

Author:
Nancy A. Melville
Publish date: March 8, 2022

Efforts to improve insulin sensitivity via the gut through fecal microbial transplantation are also making headway.

  • Read More

News

9/11 first responders show mutations linked to blood cancers

Author:
Nancy A. Melville
Publish date: March 7, 2022

Blood samples from firefighters and emergency workers at Ground Zero show higher burden of clonal hematopoiesis, suggesting need for mutational...

  • Read More

News

Evidence mounts for paramagnetic rim lesions in diagnosing MS

Author:
Nancy A. Melville
Publish date: March 2, 2022

The presence and number of iron rim lesions hold a prognostic value for long-term disability in MS.

  • Read More

News

Spinal cord atrophy predicts ‘silent progression’ in MS

Author:
Nancy A. Melville
Publish date: March 2, 2022

This is a potentially important biomarker for disease progression that may otherwise go unrecognized by clinicians and patients.

  • Read More

News

Global data suggest rising CLL incidence since 1990

Author:
Nancy A. Melville
Publish date: February 25, 2022

New global data show the rate of chronic lymphocytic leukemia increasing in the last 30 years. Is ascertainment bias a factor?

  • Read More

News

Radiofrequency ablation an option for thyroid microcarcinoma

Author:
Nancy A. Melville
Publish date: February 24, 2022

RFA might be a good option for high risk surgical patients and patients who forgo active surveillance.

  • Read More

News

IBD or something else? Key characteristics offer clues

Author:
Nancy A. Melville
Publish date: February 18, 2022

A comprehensive review details the array of immune-mediated inflammatory diseases of the GI tract that look like – but aren’t – IBD.

  • Read More

News

Male alopecia agents ranked by efficacy in meta-analysis

Author:
Nancy A. Melville
Publish date: February 11, 2022

Only three therapies are currently approved for treatment of the condition by the FDA – topical minoxidil, oral finasteride, and low-level light...

  • Read More

News

C. difficile: New vancomycin-resistant strains raise concerns

Author:
Nancy A. Melville
Publish date: February 9, 2022

“Our results may help explain a decreasing effectiveness of antibiotic-based therapy in C difficile infection.”

  • Read More

News

Stopping venetoclax treatment early reduces CLL survival outcomes

Author:
Nancy A. Melville
Publish date: February 9, 2022

Survival outcomes are decreased with early, permanent discontinuation of venetoclax but unchanged by treatment interruption, regardless of...

  • Read More

News

C. difficile: New vancomycin-resistant strains raise concerns

Author:
Nancy A. Melville
Publish date: February 7, 2022

“Our results may help explain a decreasing effectiveness of antibiotic-based therapy in C difficile infection.”

  • Read More

News

CLL patients ‘cured’: 10 years post infusion, CAR T cells persist

Author:
Nancy A. Melville
Publish date: February 3, 2022

A decade after CAR T’cell treatment, chronic leukemia patients reported “cured,” with cells still detectable.

  • Read More

News

CDC issues new pneumococcal vaccine recommendations for adults

Author:
Nancy A. Melville
Publish date: February 1, 2022

PCV15 and PREVNAR20 received approval from the FDA in July 2021, providing an impetus for the revised recommendations.

  • Read More

News

Vitamin D shows no survival benefit in nondeficient elderly

Author:
Nancy A. Melville
Publish date: February 1, 2022

“This is not dissimilar to research with many other nutrients showing that increasing intake above the adequate intake has no further health...

  • Read More

Pages

  • « first
  • …
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • last »

Privacy Policy

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2023 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close